Mint Tower Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Mint Tower Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,444	Closed	-$205K	–	451
2021 Q1	$205K	Buy	+5,444	New	+$136K	0.02%	282

Mint Tower Capital Management's FPRX Position: Q2 2021 in Review

Mint Tower Capital Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 5,444 shares — an estimated $205K sold.

Mint Tower Capital Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $205K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Mint Tower Capital Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Mint Tower Capital Management sold 5,444 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $205K.
Mint Tower Capital Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Mint Tower Capital Management's Five Prime Therapeutics, Inc. position peaked at $205K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Mint Tower Capital Management's 13F filing for Q2 2021, filed 2 Aug 2021.